Cuproptosis-related lncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p/PLAU axis
Abstract The development, progression, and curative efficacy of head and neck squamous cell carcinoma (HNSCC) are influenced by complex interactions between epithelial and immune cells. Nevertheless, the specific changes in the nature of these interactions and their underlying molecular mechanisms i...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-11-01
|
| Series: | International Journal of Oral Science |
| Online Access: | https://doi.org/10.1038/s41368-024-00314-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850061837914079232 |
|---|---|
| author | Mouyuan Sun Ning Zhan Zhan Yang Xiaoting Zhang Jingyu Zhang Lianjie Peng Yaxian Luo Lining Lin Yiting Lou Dongqi You Tao Qiu Zhichao Liu Qianting Wang Yu Liu Ping Sun Mengfei Yu Huiming Wang |
| author_facet | Mouyuan Sun Ning Zhan Zhan Yang Xiaoting Zhang Jingyu Zhang Lianjie Peng Yaxian Luo Lining Lin Yiting Lou Dongqi You Tao Qiu Zhichao Liu Qianting Wang Yu Liu Ping Sun Mengfei Yu Huiming Wang |
| author_sort | Mouyuan Sun |
| collection | DOAJ |
| description | Abstract The development, progression, and curative efficacy of head and neck squamous cell carcinoma (HNSCC) are influenced by complex interactions between epithelial and immune cells. Nevertheless, the specific changes in the nature of these interactions and their underlying molecular mechanisms in HNSCC are not yet fully understood. Cuproptosis, a form of programmed cell death that is dependent on copper, has been implicated in cancer pathogenesis. However, the understanding of cuproptosis in the context of HNSCC remains limited. In this study, we have discovered that cuproptosis-related long non-coding RNAs (CRLs) known as JPX play a role in promoting the expression of the oncogene urokinase-type plasminogen activator (PLAU) by competitively binding to miR-193b-3p in HNSCC. The increased activity of the JPX/miR-193b-3p/PLAU axis in malignant epithelial cells leads to enhanced cell proliferation, migration, and invasion in HNSCC. Moreover, the overexpression of PLAU in tumor epithelial cells facilitates its interaction with the receptor PLAUR, predominantly expressed on macrophages, thereby influencing the abnormal epithelial–immune interactome in HNSCC. Notably, the JPX inhibitor Axitinib and the PLAU inhibitor Palbociclib may not only exert their effects on the JPX/miR-193b-3p/PLAU axis that impacts the malignant tumor behaviors and the epithelial–immune cell interactions but also exhibit synergistic effects in terms of suppressing tumor cell growth and arresting cell cycle by targeting epidermal growth factor receptor (EGFR) and cyclin-dependent kinase (CDK4/6) for the treatment of HNSCC. |
| format | Article |
| id | doaj-art-d2ae146f70d64dd28e412ced68d62f25 |
| institution | DOAJ |
| issn | 2049-3169 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | International Journal of Oral Science |
| spelling | doaj-art-d2ae146f70d64dd28e412ced68d62f252025-08-20T02:50:05ZengNature Publishing GroupInternational Journal of Oral Science2049-31692024-11-0116111610.1038/s41368-024-00314-yCuproptosis-related lncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p/PLAU axisMouyuan Sun0Ning Zhan1Zhan Yang2Xiaoting Zhang3Jingyu Zhang4Lianjie Peng5Yaxian Luo6Lining Lin7Yiting Lou8Dongqi You9Tao Qiu10Zhichao Liu11Qianting Wang12Yu Liu13Ping Sun14Mengfei Yu15Huiming Wang16Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang ProvinceAbstract The development, progression, and curative efficacy of head and neck squamous cell carcinoma (HNSCC) are influenced by complex interactions between epithelial and immune cells. Nevertheless, the specific changes in the nature of these interactions and their underlying molecular mechanisms in HNSCC are not yet fully understood. Cuproptosis, a form of programmed cell death that is dependent on copper, has been implicated in cancer pathogenesis. However, the understanding of cuproptosis in the context of HNSCC remains limited. In this study, we have discovered that cuproptosis-related long non-coding RNAs (CRLs) known as JPX play a role in promoting the expression of the oncogene urokinase-type plasminogen activator (PLAU) by competitively binding to miR-193b-3p in HNSCC. The increased activity of the JPX/miR-193b-3p/PLAU axis in malignant epithelial cells leads to enhanced cell proliferation, migration, and invasion in HNSCC. Moreover, the overexpression of PLAU in tumor epithelial cells facilitates its interaction with the receptor PLAUR, predominantly expressed on macrophages, thereby influencing the abnormal epithelial–immune interactome in HNSCC. Notably, the JPX inhibitor Axitinib and the PLAU inhibitor Palbociclib may not only exert their effects on the JPX/miR-193b-3p/PLAU axis that impacts the malignant tumor behaviors and the epithelial–immune cell interactions but also exhibit synergistic effects in terms of suppressing tumor cell growth and arresting cell cycle by targeting epidermal growth factor receptor (EGFR) and cyclin-dependent kinase (CDK4/6) for the treatment of HNSCC.https://doi.org/10.1038/s41368-024-00314-y |
| spellingShingle | Mouyuan Sun Ning Zhan Zhan Yang Xiaoting Zhang Jingyu Zhang Lianjie Peng Yaxian Luo Lining Lin Yiting Lou Dongqi You Tao Qiu Zhichao Liu Qianting Wang Yu Liu Ping Sun Mengfei Yu Huiming Wang Cuproptosis-related lncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p/PLAU axis International Journal of Oral Science |
| title | Cuproptosis-related lncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p/PLAU axis |
| title_full | Cuproptosis-related lncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p/PLAU axis |
| title_fullStr | Cuproptosis-related lncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p/PLAU axis |
| title_full_unstemmed | Cuproptosis-related lncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p/PLAU axis |
| title_short | Cuproptosis-related lncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p/PLAU axis |
| title_sort | cuproptosis related lncrna jpx regulates malignant cell behavior and epithelial immune interaction in head and neck squamous cell carcinoma via mir 193b 3p plau axis |
| url | https://doi.org/10.1038/s41368-024-00314-y |
| work_keys_str_mv | AT mouyuansun cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT ningzhan cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT zhanyang cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT xiaotingzhang cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT jingyuzhang cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT lianjiepeng cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT yaxianluo cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT lininglin cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT yitinglou cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT dongqiyou cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT taoqiu cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT zhichaoliu cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT qiantingwang cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT yuliu cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT pingsun cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT mengfeiyu cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis AT huimingwang cuproptosisrelatedlncrnajpxregulatesmalignantcellbehaviorandepithelialimmuneinteractioninheadandnecksquamouscellcarcinomaviamir193b3pplauaxis |